The company expired its plan on April 25, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.28 SGD | 0.00% |
|
+1.82% | -1.75% |
Jun. 06 | Singapore Shares Remain Flat Despite Overnight Gains in Global Markets; Zheneng Jinjiang Rises 3% | MT |
Jun. 06 | Hyphens Pharma’s Subsidiary Enters Exclusive Deal with Maruho | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.75% | 64.09M | |
+26.95% | 76.24B | |
+15.06% | 8.76B | |
-1.71% | 8.17B | |
-33.62% | 6.63B | |
+20.45% | 5.53B | |
+2.13% | 4.13B | |
-9.75% | 3.8B | |
-9.46% | 3.32B | |
+7.77% | 3.2B |
- Stock Market
- Equities
- 1J5 Stock
- News Hyphens Pharma International Limited
- Hyphens Pharma International Limited's Equity Buyback announced on April 2, 2024, has expired.